Value through Innovation27 July 2016

Clinical Study Results

  • ZANTAC ® - Healthy
    Clinical Study Number 1144.3
    Study Indication Healthy
    Product ZANTAC ®
    Generic Name Ranitidine
    Lab Code
    Clinical Phase I
    Study Title

    A Phase I open-label, randomized, single dose, three-way crossover relative bioavailability study of ranitidine hydrochloride (Maximum Strength ZANTAC 150®) compared to two different 150 mg ranitidine hydrochloride oral disintegrating tablet (ODT) formulations following oral administration in fasting, healthy male volunteers

    Study Document Trial synopsis 1144.3_CO english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.